John L. Brottem - 01 Mar 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
General Counsel
Signature
John L Brottem
Issuer symbol
OM
Transactions as of
01 Mar 2022
Net transactions value
-$43,861
Form type
4
Filing time
02 Mar 2022, 15:51:59 UTC
Previous filing
17 Feb 2022
Next filing
15 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Sale $43,861 -1,003 -2.7% $43.73 36,806 01 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021.
F2 Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c).